198 related articles for article (PubMed ID: 24323278)
21. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
Ann Surg Oncol; 2014 Feb; 21(2):458-65. PubMed ID: 24132624
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
23. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.
Chapoutot C; Esslimani M; Joomaye Z; Ramos J; Perney P; Laurent C; Fabbro-Peray P; Larrey D; Domergue J; Blanc F
Gut; 2000 May; 46(5):711-4. PubMed ID: 10764717
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
[TBL] [Abstract][Full Text] [Related]
25. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.
Mazzanti R; Messerini L; Comin CE; Fedeli L; Ganne-Carrie N; Beaugrand M
World J Gastroenterol; 2007 Oct; 13(37):5009-14. PubMed ID: 17854145
[TBL] [Abstract][Full Text] [Related]
26. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.
Trevisani F; D'Intino PE; Caraceni P; Pizzo M; Stefanini GF; Mazziotti A; Grazi GL; Gozzetti G; Gasbarrini G; Bernardi M
Cancer; 1995 May; 75(9):2220-32. PubMed ID: 7536121
[TBL] [Abstract][Full Text] [Related]
27. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients.
Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Ito Y; Tamai S; Hoshino H; Inoue T; Kanisawa M
Cancer; 1994 Feb; 73(4):1149-54. PubMed ID: 7508816
[TBL] [Abstract][Full Text] [Related]
28. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
29. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
30. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.
Gawrieh S; Dakhoul L; Miller E; Scanga A; deLemos A; Kettler C; Burney H; Liu H; Abu-Sbeih H; Chalasani N; Wattacheril J
Aliment Pharmacol Ther; 2019 Oct; 50(7):809-821. PubMed ID: 31475372
[TBL] [Abstract][Full Text] [Related]
31. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
[TBL] [Abstract][Full Text] [Related]
32. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis.
Caporaso N; Romano M; Marmo R; de Sio I; Morisco F; Minerva A; Coltorti M
J Hepatol; 1991 May; 12(3):367-71. PubMed ID: 1658121
[TBL] [Abstract][Full Text] [Related]
34. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
35. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
[TBL] [Abstract][Full Text] [Related]
36. Cirrhotic cardiomyopathy: does it contribute to chronic fatigue and decreased health-related quality of life in cirrhosis?
Girgrah N; Reid G; MacKenzie S; Wong F
Can J Gastroenterol; 2003 Sep; 17(9):545-51. PubMed ID: 14532928
[TBL] [Abstract][Full Text] [Related]
37. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
[TBL] [Abstract][Full Text] [Related]
39. Impact of physical and psychological factors on health-related quality of life in adult patients with liver cirrhosis: a systematic review protocol.
Polis S; Fernandez R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):39-51. PubMed ID: 26447006
[TBL] [Abstract][Full Text] [Related]
40. Liver transplantation for hepatocellular carcinoma in cirrhotic patients.
Chui AK; Rao AR; McCaughan GW; Waugh R; Verran DJ; Koorey D; Sheil AG
Aust N Z J Surg; 1999 Nov; 69(11):798-801. PubMed ID: 10553969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
